Search
Cabaletta Bio Inc
CABAAdd to Watchlist
3.190USD
+0.200+6.69%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
355.13MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
10
analysts
Buy
Current Rating
14.714
Target Price
+392.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Cabaletta Bio Inc
CABA
10
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Cabaletta Bio Inc's price target?
Analysts forecast that Cabaletta Bio Inc's price target is USD 14.50, with the highest forecast at USD 22.00 and the lowest forecast at USD 2.00.
How have Cabaletta Bio IncCABA's recent earnings per share performed?
The market expectation was USD -0.39, while Cabaletta Bio IncCABA's earnings per share (EPS) for the previous quarter was USD -0.40. EPS for the next quarter is expected at USD -0.37.
What is the analyst rating for Cabaletta Bio Inc?
Based on the ratings of Cabaletta Bio Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.